John Militello
CIK: 0001662170
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (39 total)
- May 26, 2026RCKT
ROCKET PHARMACEUTICALS, INC.
Disposition(D)DirectStock Option (Right to Buy)
10K shares- - May 26, 2026RCKT
ROCKET PHARMACEUTICALS, INC.
Award(A)DirectStock Option (Right to Buy)
9.1K shares- - May 26, 2026RCKT
ROCKET PHARMACEUTICALS, INC.
Award(A)DirectStock Option (Right to Buy)
24.9K shares- - May 26, 2026RCKT
ROCKET PHARMACEUTICALS, INC.
Award(A)DirectStock Option (Right to Buy)
16.1K shares- - May 26, 2026RCKT
ROCKET PHARMACEUTICALS, INC.
Award(A)DirectStock Option (Right to Buy)
15K shares- - May 26, 2026RCKT
ROCKET PHARMACEUTICALS, INC.
Award(A)DirectStock Option (Right to Buy)
51.5K shares- - May 26, 2026RCKT
ROCKET PHARMACEUTICALS, INC.
Disposition(D)DirectStock Option (Right to Buy)
24.5K shares- - May 26, 2026RCKT
ROCKET PHARMACEUTICALS, INC.
Disposition(D)DirectStock Option (Right to Buy)
2K shares- - May 26, 2026RCKT
ROCKET PHARMACEUTICALS, INC.
Disposition(D)DirectStock Option (Right to Buy)
20K shares- - May 26, 2026RCKT
ROCKET PHARMACEUTICALS, INC.
Disposition(D)DirectStock Option (Right to Buy)
10K shares- - May 26, 2026RCKT
ROCKET PHARMACEUTICALS, INC.
Disposition(D)DirectStock Option (Right to Buy)
20K shares- - May 26, 2026RCKT
ROCKET PHARMACEUTICALS, INC.
Disposition(D)DirectStock Option (Right to Buy)
10K shares- - May 26, 2026RCKT
ROCKET PHARMACEUTICALS, INC.
Disposition(D)DirectStock Option (Right to Buy)
49.8K shares- - May 26, 2026RCKT
ROCKET PHARMACEUTICALS, INC.
Disposition(D)DirectStock Option (Right to Buy)
28.9K shares- - May 26, 2026RCKT
ROCKET PHARMACEUTICALS, INC.
Disposition(D)DirectStock Option (Right to Buy)
27K shares- - May 26, 2026RCKT
ROCKET PHARMACEUTICALS, INC.
Disposition(D)DirectStock Option (Right to Buy)
18K shares- - May 26, 2026RCKT
ROCKET PHARMACEUTICALS, INC.
Disposition(D)DirectStock Option (Right to Buy)
18K shares- - May 19, 2026RCKT
ROCKET PHARMACEUTICALS, INC.
Sale(S)Direct384 shares at avg. $3.01$1K - May 13, 2026RCKT
ROCKET PHARMACEUTICALS, INC.
Sale(S)Direct855 shares at avg. $3.61$3K - Feb 18, 2026RCKT
ROCKET PHARMACEUTICALS, INC.
Sale(S)Direct1.2K shares at avg. $3.34$4K - Feb 13, 2026RCKT
ROCKET PHARMACEUTICALS, INC.
Sale(S)Direct3.7K shares at avg. $3.31$12K - Feb 11, 2026RCKT
ROCKET PHARMACEUTICALS, INC.
Award(A)Direct30K shares- - Nov 18, 2025RCKT
ROCKET PHARMACEUTICALS, INC.
Sale(S)Direct1.1K shares at avg. $2.98$3K - Oct 14, 2025RCKT
ROCKET PHARMACEUTICALS, INC.
Sale(S)Direct3K shares at avg. $3.97$12K - Oct 14, 2025RCKT
ROCKET PHARMACEUTICALS, INC.
Sale(S)Direct19.8K shares at avg. $3.96$79K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| May 26, 2026 |  RCKT ROCKET PHARMACEUTICALS, INC. | Disposition(D) Stock Option (Right to Buy) | 10,000 | - | - | Direct |
| May 26, 2026 | RCKT ROCKET PHARMACEUTICALS, INC. | Award(A) Stock Option (Right to Buy) | 9,091 | - | - | Direct |
| May 26, 2026 | RCKT ROCKET PHARMACEUTICALS, INC. | Award(A) Stock Option (Right to Buy) | 24,899 | - | - | Direct |
| May 26, 2026 | RCKT ROCKET PHARMACEUTICALS, INC. | Award(A) Stock Option (Right to Buy) | 16,061 | - | - | Direct |
| May 26, 2026 | RCKT ROCKET PHARMACEUTICALS, INC. | Award(A) Stock Option (Right to Buy) | 15,002 | - | - | Direct |
| May 26, 2026 | RCKT ROCKET PHARMACEUTICALS, INC. | Award(A) Stock Option (Right to Buy) | 51,509 | - | - | Direct |
| May 26, 2026 | RCKT ROCKET PHARMACEUTICALS, INC. | Disposition(D) Stock Option (Right to Buy) | 24,545 | - | - | Direct |
| May 26, 2026 | RCKT ROCKET PHARMACEUTICALS, INC. | Disposition(D) Stock Option (Right to Buy) | 2,000 | - | - | Direct |
| May 26, 2026 | RCKT ROCKET PHARMACEUTICALS, INC. | Disposition(D) Stock Option (Right to Buy) | 20,000 | - | - | Direct |
| May 26, 2026 | RCKT ROCKET PHARMACEUTICALS, INC. | Disposition(D) Stock Option (Right to Buy) | 10,000 | - | - | Direct |
| May 26, 2026 | RCKT ROCKET PHARMACEUTICALS, INC. | Disposition(D) Stock Option (Right to Buy) | 20,000 | - | - | Direct |
| May 26, 2026 | RCKT ROCKET PHARMACEUTICALS, INC. | Disposition(D) Stock Option (Right to Buy) | 10,000 | - | - | Direct |
| May 26, 2026 | RCKT ROCKET PHARMACEUTICALS, INC. | Disposition(D) Stock Option (Right to Buy) | 49,798 | - | - | Direct |
| May 26, 2026 | RCKT ROCKET PHARMACEUTICALS, INC. | Disposition(D) Stock Option (Right to Buy) | 28,910 | - | - | Direct |
| May 26, 2026 | RCKT ROCKET PHARMACEUTICALS, INC. | Disposition(D) Stock Option (Right to Buy) | 27,003 | - | - | Direct |
| May 26, 2026 | RCKT ROCKET PHARMACEUTICALS, INC. | Disposition(D) Stock Option (Right to Buy) | 18,000 | - | - | Direct |
| May 26, 2026 | RCKT ROCKET PHARMACEUTICALS, INC. | Disposition(D) Stock Option (Right to Buy) | 18,000 | - | - | Direct |
| May 19, 2026 | RCKT ROCKET PHARMACEUTICALS, INC. | Sale(S) | 384 | $3.01 | $1,157 | Direct |
| May 13, 2026 | RCKT ROCKET PHARMACEUTICALS, INC. | Sale(S) | 855 | $3.61 | $3,083 | Direct |
| Feb 18, 2026 | RCKT ROCKET PHARMACEUTICALS, INC. | Sale(S) | 1,157 | $3.34 | $3,862 | Direct |
| Feb 13, 2026 | RCKT ROCKET PHARMACEUTICALS, INC. | Sale(S) | 3,726 | $3.31 | $12,341 | Direct |
| Feb 11, 2026 | RCKT ROCKET PHARMACEUTICALS, INC. | Award(A) | 29,982 | - | $0 | Direct |
| Nov 18, 2025 | RCKT ROCKET PHARMACEUTICALS, INC. | Sale(S) | 1,086 | $2.98 | $3,240 | Direct |
| Oct 14, 2025 | RCKT ROCKET PHARMACEUTICALS, INC. | Sale(S) | 3,005 | $3.97 | $11,930 | Direct |
| Oct 14, 2025 | RCKT ROCKET PHARMACEUTICALS, INC. | Sale(S) | 19,841 | $3.96 | $78,570 | Direct |
1-25 of 39 transactions
About Militello John
Militello John (SEC CIK 0001662170) files insider reports with the SEC as Chief Financial Officer of IRulya Therapeutics Inc. (IRLA) and Officer of ROCKET PHARMACEUTICALS, INC. (RCKT).
Signal8 holds 20 ownership filings by Militello John (1 Form 3, 19 Form 4), filed between Nov 4, 2024 and Oct 19, 2026. Those filings report 39 transactions, from Oct 31, 2024 to May 26, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Militello John's filings is in NEW HAVEN, CT.
Recent filings by Militello John
- May 26, 2026: Disposition to issuer transaction of RCKT derivative securities (Form 4, code D).
- May 26, 2026: Grants or awards of RCKT derivative securities (5 lines, Form 4, code A).
- May 26, 2026: Disposition to issuer transactions of RCKT derivative securities (11 lines, Form 4, code D).
- May 19, 2026: Open-market sale of RCKT shares (Form 4, code S).
- May 13, 2026: Open-market sale of RCKT shares (Form 4, code S).
Other insiders filing for IRulya Therapeutics Inc. (IRLA)
- Bonuccelli Catherine M., Director
- Valentine James Elwood, Director
- Wise John Drayton, Director
- Fandrick Keith R., Chief Operating Officer
- PATTERSON LEONE D, Director